Thus, activation of hepatic AMPK downstream of KISS1R can alleviate DNL by decreasing SREBP-1c levels, thereby decreasing CIDEA and lipogenic genes involved in hepatic steatosis (Figure 6D). Here, KISS1R is linked to fatty liver disease.